Haemonetics Corp. (HAE) Tops Q3 EPS by 6c; Affirms FY12 EPS Outlook

January 30, 2012 8:04 AM EST
Get Alerts HAE Hot Sheet
Price: $90.80 +0.46%

Financial Fact:
Net revenues: 220.25M

Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.86, $0.06 better than the analyst estimate of $0.80. Revenue for the quarter came in at $191.2 million versus the consensus estimate of $186.21 million.

Affirms outlook.

For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings